Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biofrontera (BFRI)
NASDAQ:BFRI
Holding BFRI?
Track your performance easily
BFRI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.61 - $3.90
Previous Close$0.98
Volume154.71K
Average Volume (3M)2.93M
Market Cap
$7.58M
Enterprise Value$5.70M
Total Cash (Recent Filing)$2.87M
Total Debt (Recent Filing)$994.00K
Price to Earnings (P/E)―
Beta0.49
Next Earnings
Apr 04, 2025EPS Estimate
-$0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.27
Shares Outstanding7,749,211
10 Day Avg. Volume2,264,688
30 Day Avg. Volume2,926,091
Standard Deviation0.28
R-Squared0.00485
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)1.38
Price to Sales (P/S)0.21
Price to Cash Flow (P/CF)-1.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.16
Enterprise Value/Gross Profit0.34
Enterprise Value/Ebitda-0.72
Forecast
1Y Price Target
$11.50Price Target Upside1075.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Biofrontera News
PremiumCompany Announcements
Biofrontera Secures $4.2M for Strategic Growth Initiatives
PremiumCompany Announcements
Biofrontera Inc. Reports Q3 2024 Earnings Growth
PremiumCompany Announcements
Biofrontera Announces Promising Phase 3 Study Results
PremiumCompany Announcements
Biofrontera’s Ameluz Gel FDA Approval for Higher DosageBFRI FAQ
What was Biofrontera’s price range in the past 12 months?
Biofrontera lowest stock price was $0.61 and its highest was $3.90 in the past 12 months.
What is Biofrontera’s market cap?
Currently, no data Available
When is Biofrontera’s upcoming earnings report date?
Biofrontera’s upcoming earnings report date is Apr 04, 2025 which is in 103 days.
How were Biofrontera’s earnings last quarter?
Biofrontera released its earnings results on Nov 13, 2024. The company reported -$0.98 earnings per share for the quarter, missing the consensus estimate of -$0.835 by -$0.145.
Is Biofrontera overvalued?
According to Wall Street analysts Biofrontera’s price is currently Undervalued.
Does Biofrontera pay dividends?
Biofrontera does not currently pay dividends.
What is Biofrontera’s EPS estimate?
Biofrontera’s EPS estimate is -$0.03.
How many shares outstanding does Biofrontera have?
Biofrontera has 7,749,211 shares outstanding.
What happened to Biofrontera’s price movement after its last earnings report?
Biofrontera reported an EPS of -$0.98 in its last earnings report, missing expectations of -$0.835. Following the earnings report the stock price went down -15.663%.
Which hedge fund is a major shareholder of Biofrontera?
Currently, no hedge funds are holding shares in BFRI
---
Biofrontera Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.50 (1075.27% Upside)
$11.50 (1075.27% Upside)
Blogger Sentiment
Bullish
BFRI Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.9%
Last 30 Days ▼ 6.9%
Last 30 Days ▼ 6.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-71.23%
12-Months-Change
Fundamentals
Return on Equity
-390.90%
Trailing 12-Months
Asset Growth
-45.71%
Trailing 12-Months
Company Description
Biofrontera
Biofrontera Inc is a biopharmaceutical company specializing in the commercialization of pharmaceutical products for the treatment of dermatological conditions, diseases caused by exposure to sunlight that result in sun damage to the skin. Its licensed products focus on the treatment of actinic keratoses, which are skin lesions that can sometimes lead to skin cancer. It also markets a topical antibiotic for the treatment of impetigo, a bacterial skin infection.
---
BFRI Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted Biofrontera's strong revenue growth and effective cost management, alongside strategic initiatives such as the introduction of new products and improved formulations. However, challenges remain with increased costs of revenues and ongoing trial expenses impacting financials. Despite these challenges, the overall sentiment is positive due to significant achievements and strategic positioning for future growth.Read More>---
BFRI Stock 12 Month Forecast
Average Price Target
$11.50
▲(1075.27% Upside)
Technical Analysis
Best Analysts Covering BFRI
1 Year
1 Year Success Rate
1/12 ratings generated profit
1 Year Average Return
-59.02%
reiterated a buy rating 28 days ago
Copying Bruce Jackson's trades and holding each position for 1 Year would result in 8.33% of your transactions generating a profit, with an average return of -59.02% per trade.
---